タクロリムスの世界市場レポート 2024年

タクロリムス市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.5％で84億7,000万米ドルに成長します。予測期間中に予想される成長の要因としては、治療用途の拡大、新たな適応症に対する規制当局の承認、研究開発投資の増加、免疫抑制療法に対する認識と受容の高まり、新興国市場におけるヘルスケアインフラの拡大、治療ガイドラインやプロトコルの進化などが挙げられます。予測期間中に予想される主な動向には、個別化医療アプローチの採用拡大、ドラッグデリバリー・システムの進歩、自己免疫疾患への応用拡大、新興国市場での需要拡大、生物学的同等性試験の重視の高まり、新規製剤の開発、最適な投与レジメンのための薬理遺伝学の統合などがあります。

臓器移植手術の増加動向は、今後数年間のタクロリムス市場の拡大に拍車をかけるものと思われます。臓器移植は、機能不全に陥った臓器をドナーの健康な臓器と外科的に置き換えるもので、患者の転帰と生活の質を改善するために不可欠な処置です。医療技術の進歩、洗練された手術手技、臓器提供に関する意識の向上、移植後のケアの改善などの要因が、臓器移植率の増加に寄与しています。タクロリムスは、T細胞の活性化を抑制し、サイトカイン産生を減少させることにより、レシピエントの免疫系による移植臓器の拒絶反応を防ぐという、臓器移植において重要な役割を果たしています。例えば、2024年1月、米国保健社会福祉省は、死亡ドナーおよび生体ドナーの両方からの臓器移植件数は合計46,632件で、2022年から8.7％、2021年から12.7％増加したと報告しています。その結果、臓器移植手術の急増がタクロリムス市場の主要促進要因となっています。

タクロリムス市場の新興国開拓企業は、タクロリムス軟膏のような先進的製剤の開発に注力し、皮膚科疾患の革新的治療に対する需要の高まりに対応するとともに、患者ケアの向上に努めています。タクロリムス軟膏は、免疫抑制剤タクロリムスを含有し、主に炎症性皮膚疾患の治療に使用されます。例えば、2023年8月、インドの製薬会社であるグレンマーク社は、米国食品医薬品局（US FDA）から、プロトピック軟膏0.03%のジェネリック医薬品であるタクロリムス軟膏0.03%の承認を取得しました。本剤は、炎症、発赤、かゆみを特徴とする中等度から重度のアトピー性皮膚炎の治療に使用されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のタクロリムス市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のタクロリムス市場の実績：規模と成長、2018年～2023年
• 世界のタクロリムス市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のタクロリムス市場：製品タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
• タクロリムスカプセルとタブレット
• タクロリムス軟膏
• タクロリムスインジェクション
• タクロリムス顆粒
• 世界のタクロリムス市場：用途別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 免疫抑制
• 皮膚炎
• その他の用途
• 世界のタクロリムス市場：エンドユーザー別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 臓器移植センター
• 病院
• クリニック
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界のタクロリムス市場：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界のタクロリムス市場：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• タクロリムス市場：競合情勢
• タクロリムス市場：企業プロファイル
  • Sinopharm Chuankang Pharmaceutical
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Novartis AG
  • Viatris Inc.

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Limited
• Astellas Pharma Inc
• Sandoz Inc
• Huadong Medicine Co Ltd
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Hikma Pharmaceuticals
• Lupin Limited
• Zhejiang Hisun Pharmaceutical Co. Ltd.
• LEO Pharma A/S
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Limited
• Alembic Pharmaceuticals Limited
• Wockhardt Limited
• Biocon Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Tacrolimus is an immunosuppressive medication employed to forestall organ rejection following transplantation. It operates by reducing immune system activity, thus preventing the transplanted organ from being attacked.

The main product types of tacrolimus encompass tacrolimus capsules and tablets, tacrolimus ointment, tacrolimus injection, and tacrolimus granules. Tacrolimus capsules and tablets are pharmaceutical formulations containing tacrolimus, utilized to thwart organ rejection post-transplantation. They serve various purposes including immunosuppression and dermatitis management, and are utilized by diverse end users such as organ transplant centers, hospitals, clinics, and others.

The tacrolimus market research report is one of a series of new reports from The Business Research Company that provides tacrolimus market statistics, including tacrolimus industry global market size, regional shares, competitors with a tacrolimus market share, detailed tacrolimus market segments, market trends, and opportunities, and any further data you may need to thrive in the tacrolimus industry. This tacrolimus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tacrolimus market size has grown strongly in recent years. It will grow from $6.2 billion in 2023 to $6.59 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth observed during the historic period can be attributed to several factors, including advancements in transplantation medicine, increased organ transplant procedures, regulatory approvals, expanded applications in dermatology, the prevalence of autoimmune diseases, increased research investments, and enhanced drug delivery technologies.

The tacrolimus market size is expected to see strong growth in the next few years. It will grow to $8.47 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The anticipated growth in the forecast period can be attributed to several factors, including expanded therapeutic applications, regulatory approvals for new indications, increased investment in research and development, growing awareness and acceptance of immunosuppressant therapies, expanding healthcare infrastructure in emerging markets, and evolving treatment guidelines and protocols. Major trends expected in the forecast period include increased adoption of personalized medicine approaches, advancements in drug delivery systems, expanding applications in autoimmune disorders, rising demand in emerging markets, growing emphasis on bioequivalence studies, development of novel formulations, and integration of pharmacogenomics for optimized dosing regimens.

The upward trend in organ transplant procedures is poised to fuel the expansion of the tacrolimus market in the coming years. Organ transplantation involves surgically replacing a dysfunctional organ with a healthy one from a donor, a procedure vital for improving patient outcomes and quality of life. Factors such as advancements in medical technology, refined surgical techniques, increased awareness about organ donation, and improved post-transplant care contribute to the growing rates of organ transplantation. Tacrolimus plays a crucial role in organ transplantation by inhibiting T-cell activation and reducing cytokine production, thus preventing rejection of the transplanted organ by the recipient's immune system. For instance, in January 2024, the US Department of Health and Human Services reported a total of 46,632 organ transplant procedures from both deceased and living donors, marking an 8.7% increase from 2022 and a 12.7% increase from 2021. Consequently, the surge in organ transplant procedures is a key driver of the tacrolimus market.

Leading companies in the tacrolimus market are focusing on the development of advanced formulations, such as tacrolimus ointments, to cater to the rising demand for innovative treatments for dermatological conditions while also improving patient care. Tacrolimus ointment, containing the immunosuppressive agent tacrolimus, is primarily used to treat inflammatory skin conditions. For example, in August 2023, Glenmark, a pharmaceutical company based in India, received approval from the United States Food and Drug Administration (US FDA) for Tacrolimus Ointment 0.03%, a generic version of Protopic Ointment 0.03%. This medication is prescribed to manage moderate-to-severe atopic dermatitis, a skin condition characterized by inflammation, redness, and itching.

In January 2022, Aequus Pharmaceuticals Inc., a Canadian pharmaceutical company developing Tacrolimus Immediate Release, forged a partnership with Sandoz Inc. This collaboration aims to drive market growth and enhance the presence of tacrolimus, ensuring continued access to a cost-effective and high-quality solution for transplant-related needs across Canada. Sandoz Inc., headquartered in Switzerland, specializes in the production of generic medicines.

Major companies operating in the tacrolimus market are Sinopharm Chuankang Pharmaceutical, F. Hoffmann-La Roche AG, Abbott Laboratories, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc, Sandoz Inc, Huadong Medicine Co Ltd, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals, Lupin Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Wockhardt Limited, Biocon Ltd., Zydus Lifesciences Limited, Panacea Biotec, RPG Life Science, Sun Pharmaceutical Industries Limited, Tecoland Corporation

North America was the largest region in the tacrolimus market in 2023 and 2024. The regions covered in the tacrolimus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tacrolimus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tacrolimus market consists of sales of oral suspension, extended-release capsules, and extended-release tablets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tacrolimus Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tacrolimus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tacrolimus? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tacrolimus market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tacrolimus Capsules And Tablets; Tacrolimus Ointment; Tacrolimus Injection; Tacrolimus Granules
• 2) By Application: Immunosuppression; Dermatitis; Other Applications
• 3) By End User: Organ Transplant Centers; Hospitals; Clinics; Other End Users
• Companies Mentioned: Sinopharm Chuankang Pharmaceutical; F. Hoffmann-La Roche AG; Abbott Laboratories; Novartis AG; Viatris Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tacrolimus Market Characteristics

3. Tacrolimus Market Trends And Strategies

4. Tacrolimus Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Tacrolimus Market Size and Growth

• 5.1. Global Tacrolimus Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Tacrolimus Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Tacrolimus Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tacrolimus Market Segmentation

• 6.1. Global Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tacrolimus Capsules And Tablets
• Tacrolimus Ointment
• Tacrolimus Injection
• Tacrolimus Granules
• 6.2. Global Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Immunosuppression
• Dermatitis
• Other Applications
• 6.3. Global Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Organ Transplant Centers
• Hospitals
• Clinics
• Other End Users

7. Tacrolimus Market Regional And Country Analysis

• 7.1. Global Tacrolimus Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Tacrolimus Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tacrolimus Market

• 8.1. Asia-Pacific Tacrolimus Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tacrolimus Market

• 9.1. China Tacrolimus Market Overview
• 9.2. China Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tacrolimus Market

• 10.1. India Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tacrolimus Market

• 11.1. Japan Tacrolimus Market Overview
• 11.2. Japan Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tacrolimus Market

• 12.1. Australia Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tacrolimus Market

• 13.1. Indonesia Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tacrolimus Market

• 14.1. South Korea Tacrolimus Market Overview
• 14.2. South Korea Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tacrolimus Market

• 15.1. Western Europe Tacrolimus Market Overview
• 15.2. Western Europe Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tacrolimus Market

• 16.1. UK Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tacrolimus Market

• 17.1. Germany Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tacrolimus Market

• 18.1. France Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tacrolimus Market

• 19.1. Italy Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tacrolimus Market

• 20.1. Spain Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tacrolimus Market

• 21.1. Eastern Europe Tacrolimus Market Overview
• 21.2. Eastern Europe Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tacrolimus Market

• 22.1. Russia Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tacrolimus Market

• 23.1. North America Tacrolimus Market Overview
• 23.2. North America Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tacrolimus Market

• 24.1. USA Tacrolimus Market Overview
• 24.2. USA Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tacrolimus Market

• 25.1. Canada Tacrolimus Market Overview
• 25.2. Canada Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tacrolimus Market

• 26.1. South America Tacrolimus Market Overview
• 26.2. South America Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tacrolimus Market

• 27.1. Brazil Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tacrolimus Market

• 28.1. Middle East Tacrolimus Market Overview
• 28.2. Middle East Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tacrolimus Market

• 29.1. Africa Tacrolimus Market Overview
• 29.2. Africa Tacrolimus Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Tacrolimus Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Tacrolimus Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tacrolimus Market Competitive Landscape And Company Profiles

• 30.1. Tacrolimus Market Competitive Landscape
• 30.2. Tacrolimus Market Company Profiles
  • 30.2.1. Sinopharm Chuankang Pharmaceutical
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F. Hoffmann-La Roche AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Laboratories
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Viatris Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Tacrolimus Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Limited
• 31.2. Astellas Pharma Inc
• 31.3. Sandoz Inc
• 31.4. Huadong Medicine Co Ltd
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Cipla Limited
• 31.7. Hikma Pharmaceuticals
• 31.8. Lupin Limited
• 31.9. Zhejiang Hisun Pharmaceutical Co. Ltd.
• 31.10. LEO Pharma A/S
• 31.11. Glenmark Pharmaceuticals Ltd.
• 31.12. Torrent Pharmaceuticals Limited
• 31.13. Alembic Pharmaceuticals Limited
• 31.14. Wockhardt Limited
• 31.15. Biocon Ltd.

32. Global Tacrolimus Market Competitive Benchmarking

33. Global Tacrolimus Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tacrolimus Market

35. Tacrolimus Market Future Outlook and Potential Analysis

• 35.1 Tacrolimus Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Tacrolimus Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Tacrolimus Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer